{"id":1529,"date":"2018-09-13T16:58:33","date_gmt":"2018-09-13T16:58:33","guid":{"rendered":"http:\/\/shaheennews.com\/shahennews.com\/eng\/2018\/09\/13\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/"},"modified":"2018-09-13T16:58:33","modified_gmt":"2018-09-13T16:58:33","slug":"optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use","status":"publish","type":"post","link":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/","title":{"rendered":"OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use"},"content":{"rendered":"<p style=\"text-align: left;\"><img loading=\"lazy\" decoding=\"async\" class=\" size-full wp-image-1528\" src=\"http:\/\/shaheennews.com\/shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg\" alt=\"\u0627\u0644\u0634\u0627\u0647\u064a\u0646 \u0646\u064a\u0648\u0632\" dir=\"rtl\" style=\"margin: 5px auto; display: block;\" width=\"527\" height=\"275\" srcset=\"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg 600w, https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw-300x157.jpg 300w\" sizes=\"auto, (max-width: 527px) 100vw, 527px\" \/><\/p>\n<p style=\"text-align: left;\">&nbsp;<\/p>\n<p style=\"text-align: left;\">&nbsp;<\/p>\n<p style=\"text-align: left;\">&nbsp;<\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\">Shaheennews &#8211;&nbsp;<\/span><\/p>\n<p style=\"text-align: left;\">&nbsp;<\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\">SAN JOSE, Calif. -[ AETOS Wire ]<\/span><\/p>\n<p style=\"text-align: left;\">&nbsp;<\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\">(BUSINESS WIRE)&#8211; OptraSCAN\u00ae, the leading end-to-end digital pathology solution provider, today announced that their whole-slide scanners have<\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\"> received CE Mark approval for European Standards applicable to &#8220;In-Vitro Diagnostics Directive (IVDD)&#8221; 98\/79\/EC for in-vitro diagnostics use. The CE Mark will allow OptraSCAN&#8217;s scanners to be sold in countries belonging to or affiliated to European Union (EU) that recognizes CE Mark.<\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\">OptraSCAN&#8217;s On-Demand desktop scanning systems are cloud-enabled and provide the ultimate flexibility for storing, archiving and managing digital images and metadata. These small footprint, low and high throughput scanners are fully-integrated, affordable and lightweight that can easily fit into small workspaces.<\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\">&#8220;The CE Mark specifically addresses the safety, quality and performance of In-Vitro Diagnostic Directives (IVDDs) (98\/79\/EC), and certifies that it has been created and manufactured to meet strict safety and health criteria for distribution in the European Union (EU). We are very pleased to receive this approval as it underlines our commitment in providing robust, high-quality solutions to meet the needs of diverse healthcare providers in the EU and affiliated countries,&#8221; said Abhi Gholap, Founder &amp; CEO.<\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\">He further added, &#8220;This is a significant milestone for OptraSCAN to support pathologists from the European continent towards adopting Digital Pathology for their requirements.&#8221;<\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\">About OptraSCAN:<\/span><\/p>\n<p style=\"text-align: left;\"><span style=\"font-size: 12pt; font-family: 'times new roman', times;\">OptraSCAN\u00ae (www.optrascan.com), ISO 13485 certified, is an end-to-end digital pathology solution provider. OptraSCAN is focused on delivering fully integrated, affordable solutions that will maximize your return on investment and improve the performance of your pathology services. OptraSCAN\u00ae is a pioneer in the On-Demand Digital Pathology\u00ae System and is working to eliminate the barriers to &#8220;Go Digital&#8221; no matter the size of the pathology lab, the lab&#8217;s throughput or global location.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; &nbsp; Shaheennews &#8211;&nbsp; &nbsp; SAN JOSE, Calif. -[ AETOS Wire ] &nbsp; (BUSINESS WIRE)&#8211; OptraSCAN\u00ae, the leading end-to-end digital pathology solution provider, today announced that their whole-slide scanners have received CE Mark approval for European Standards applicable to &#8220;In-Vitro Diagnostics Directive (IVDD)&#8221; 98\/79\/EC for in-vitro diagnostics use. The CE Mark will allow OptraSCAN&#8217;s &hellip;<\/p>\n","protected":false},"author":1,"featured_media":1527,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-1529","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use - Shahennews Eng<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use - Shahennews Eng\" \/>\n<meta property=\"og:description\" content=\"&nbsp; &nbsp; &nbsp; Shaheennews &#8211;&nbsp; &nbsp; SAN JOSE, Calif. -[ AETOS Wire ] &nbsp; (BUSINESS WIRE)&#8211; OptraSCAN\u00ae, the leading end-to-end digital pathology solution provider, today announced that their whole-slide scanners have received CE Mark approval for European Standards applicable to &#8220;In-Vitro Diagnostics Directive (IVDD)&#8221; 98\/79\/EC for in-vitro diagnostics use. The CE Mark will allow OptraSCAN&#8217;s &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/\" \/>\n<meta property=\"og:site_name\" content=\"Shahennews Eng\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-13T16:58:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"313\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/\",\"url\":\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/\",\"name\":\"OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use - Shahennews Eng\",\"isPartOf\":{\"@id\":\"https:\/\/www.shahennews.com\/eng\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg\",\"datePublished\":\"2018-09-13T16:58:33+00:00\",\"author\":{\"@id\":\"https:\/\/www.shahennews.com\/eng\/#\/schema\/person\/1e35b73d0d0fd09901a9f709a192a595\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#primaryimage\",\"url\":\"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg\",\"contentUrl\":\"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg\",\"width\":600,\"height\":313,\"caption\":\"\u0627\u0644\u0634\u0627\u0647\u064a\u0646 \u0646\u064a\u0648\u0632\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\/\/www.shahennews.com\/eng\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.shahennews.com\/eng\/#website\",\"url\":\"https:\/\/www.shahennews.com\/eng\/\",\"name\":\"Shahennews Eng\",\"description\":\"Shahennews.com\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.shahennews.com\/eng\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.shahennews.com\/eng\/#\/schema\/person\/1e35b73d0d0fd09901a9f709a192a595\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.shahennews.com\/eng\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d38282ac2e670f57d1836c717b1e8b7d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d38282ac2e670f57d1836c717b1e8b7d?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/www.shahennews.com\/eng\/archives\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use - Shahennews Eng","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/","og_locale":"en_US","og_type":"article","og_title":"OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use - Shahennews Eng","og_description":"&nbsp; &nbsp; &nbsp; Shaheennews &#8211;&nbsp; &nbsp; SAN JOSE, Calif. -[ AETOS Wire ] &nbsp; (BUSINESS WIRE)&#8211; OptraSCAN\u00ae, the leading end-to-end digital pathology solution provider, today announced that their whole-slide scanners have received CE Mark approval for European Standards applicable to &#8220;In-Vitro Diagnostics Directive (IVDD)&#8221; 98\/79\/EC for in-vitro diagnostics use. The CE Mark will allow OptraSCAN&#8217;s &hellip;","og_url":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/","og_site_name":"Shahennews Eng","article_published_time":"2018-09-13T16:58:33+00:00","og_image":[{"width":600,"height":313,"url":"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/","url":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/","name":"OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use - Shahennews Eng","isPartOf":{"@id":"https:\/\/www.shahennews.com\/eng\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#primaryimage"},"image":{"@id":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#primaryimage"},"thumbnailUrl":"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg","datePublished":"2018-09-13T16:58:33+00:00","author":{"@id":"https:\/\/www.shahennews.com\/eng\/#\/schema\/person\/1e35b73d0d0fd09901a9f709a192a595"},"breadcrumb":{"@id":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#primaryimage","url":"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg","contentUrl":"https:\/\/www.shahennews.com\/eng\/wp-content\/uploads\/2018\/09\/1536830589_lw.jpg","width":600,"height":313,"caption":"\u0627\u0644\u0634\u0627\u0647\u064a\u0646 \u0646\u064a\u0648\u0632"},{"@type":"BreadcrumbList","@id":"https:\/\/www.shahennews.com\/eng\/archives\/1529\/optrascan-receives-ce-mark-approval-for-in-vitro-diagnostics-use\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/www.shahennews.com\/eng\/"},{"@type":"ListItem","position":2,"name":"OptraSCAN\u00ae Receives CE Mark Approval for In-Vitro Diagnostics Use"}]},{"@type":"WebSite","@id":"https:\/\/www.shahennews.com\/eng\/#website","url":"https:\/\/www.shahennews.com\/eng\/","name":"Shahennews Eng","description":"Shahennews.com","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.shahennews.com\/eng\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.shahennews.com\/eng\/#\/schema\/person\/1e35b73d0d0fd09901a9f709a192a595","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.shahennews.com\/eng\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d38282ac2e670f57d1836c717b1e8b7d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d38282ac2e670f57d1836c717b1e8b7d?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.shahennews.com\/eng\/archives\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/posts\/1529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/comments?post=1529"}],"version-history":[{"count":0,"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/posts\/1529\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/media\/1527"}],"wp:attachment":[{"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/media?parent=1529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/categories?post=1529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.shahennews.com\/eng\/wp-json\/wp\/v2\/tags?post=1529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}